COVID-19 vaccines 87% effective at preventing hospitalization in immunosuppressed patients

Three doses of either the BNT162b2 or mRNA-1273 vaccine are 87% effective at preventing hospitalization due to COVID-19 among patients taking immunosuppressive drugs, according to data published in The Lancet Rheumatology.
“Studies indicating reduced immune response to COVID-19 vaccination among individuals taking immunosuppressive medications have led to concerns regarding the effectiveness of vaccines within this group,” Malcolm Risk, MA, and Lili Zhao, PhD, both of the University of Michigan, in Ann Arbor, told Healio in a joint statement. “Estimating vaccine effectiveness

Three doses of either the BNT162b2 or mRNA-1273 vaccine are 87% effective at preventing hospitalization due to COVID-19 among patients taking immunosuppressive drugs, according to data published in The Lancet Rheumatology.
“Studies indicating reduced immune response to COVID-19 vaccination among individuals taking immunosuppressive medications have led to concerns regarding the effectiveness of vaccines within this group,” Malcolm Risk, MA, and Lili Zhao, PhD, both of the University of Michigan, in Ann Arbor, told Healio in a joint statement. “Estimating vaccine effectiveness